Inclusive Clinical Trials: AbbVie & Sasha Tyndale
- Pharmaceutical company AbbVie is placing a significant emphasis on inclusive clinical research to ensure medicines are both accessible and effective for a wide range of people.
- Sasha Tyndale, director of Diversity and Patient Inclusion at AbbVie, is spearheading thes efforts.
- Tyndale stresses the importance of humanizing the healthcare experience by listening to patient stories and tackling the challenges they face.
AbbVie is revolutionizing clinical research by prioritizing diversity and inclusion, ensuring that medicines are effective and accessible for everyone. Sasha tyndale leads the charge, championing patient perspectives and breaking down barriers to participation in clinical trials. Through the ADMIRE program, AbbVie actively engages underrepresented healthcare professionals, fostering a more inclusive environment.The company humanizes the healthcare experience by valuing patient stories and simplifying clinical trial materials. AbbVie is improving its clinical development processes and collaborating with community organizations to broaden trial access.This commitment to inclusive clinical trials reflects AbbVie’s dedication to creating medications for all, offering critical insights.News Directory 3 highlights AbbVie’s patient-focused approach. Discover what’s next as AbbVie continues to lead the way in inclusive healthcare.
AbbVie Prioritizes Diversity and Inclusion in Clinical Research
Updated June 15, 2025
Pharmaceutical company AbbVie is placing a significant emphasis on inclusive clinical research to ensure medicines are both accessible and effective for a wide range of people. Diseases affect everyone, and AbbVie aims to reflect this reality in its research programs.
Sasha Tyndale, director of Diversity and Patient Inclusion at AbbVie, is spearheading thes efforts. Her team integrates patient perspectives into the design of clinical programs, proactively addressing potential barriers to participation. A key initiative is the ADMIRE program, which focuses on engaging healthcare professionals from underrepresented communities in research.
Tyndale stresses the importance of humanizing the healthcare experience by listening to patient stories and tackling the challenges they face. AbbVie is making foundational changes to its clinical development processes and partnering with community organizations to broaden access to clinical trials. This includes simplifying the language used in study materials.
what’s next
AbbVie encourages individuals to become advocates for inclusive healthcare by educating themselves and others about the importance of diversity in clinical research and the clinical research program.